Spore.Bio
Startup · Paris, France
Spore.Bio is a Paris-based biotech developing AI-driven microbiology testing for the food, beverage, cosmetics and pharmaceutical industries. Its technology uses spectroscopic analysis combined with machine learning to detect, quantify and identify micro-organisms directly from a sample without traditional culturing, enrichment or staining, reducing testing time from days to minutes. The approach is intended to let manufacturers identify contamination risks quickly on or near the production line. The company raised a $23M Series A in February 2025 led by Singular, building on an earlier pre-seed round, and in January 2026 announced multi-million funding from the Google.org Fund for AI in Science.
Connection map
Drag nodes to rearrange · scroll or pinch to zoom · click a node to open it